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INTRODUCTION
Alexander Tralles (525-605) from Byzantine
Empire is the first doctor who reported the existence
of gallstone disease. Gallstone disease can affect
people of all social class, race, either young or old,
women or men, regardless of their health status.
However, the prevalence is increasing with age and
three times more common in women than in men. 1 In
the western world, gallstone is one of the most
frequent digestive problems that cause hospital admis-
sion. In the US among the adult population, 10-15%
(more than 20,000,000) people suffer from gallstone;
there are more than one million new patients annually,
and more than 600,000 patients undergo
cholecystectomy each year. 1
Gallstone and Diabetes Mellitus
Hery Djagat Purnomo, Hirlan
Division of Gastroentero-hepatology, Department of Internal Medicine
Faculty of Medicine, University of Diponegoro/Dr. Kariadi General Hospital, Semarang
ABSTRACT
Diabetes Mellitus (DM) is a metabolic disease which has high prevalence among the population. The
prevalence is increasing in accordance to life style changes in the society. Gallstone is frequently found
in diabetic patients especially in women with type 2 DM. Nevertheless, studies on the prevalence of
gallstone among diabetic patients population have shown inconsistent/contradictive results.
Insulin resistance which is frequently found in type 2 DM patients is the underlying factor that
correlates obesity, central adiposity, and low physical activity with gallstone disease. Two important
physiological reasons in diabetic patients that may increase the risk of gallstone formation are:
(1) Increased total cholesterol synthesis that causes bile becomes more easily transformed into cholesterol
stone (lithogenic); (2) Diabetic patients have larger size and probably reduced motility of the gallbladder
that cause increased formation of cholesterol crystals. However, recent study demonstrated that DM that
merely exists without any contribution of other factors is not significant to increase the risk of gallstone
formation.
The gallstone management in diabetic patients is the same as the management in non-diabetic patients.
Elective surgery with laparoscopic cholecystectomy is the treatment of choice for symptomatic cases.
Drug treatment is indicated for patients with cholesterol stone, small stone (diameter <5 mm), and
well-functioned cystic duct.
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With the changing life style that adopt western
culture, increasing prevalence of obesity, diabetes,
sedentary life style, excessive fat consumption in
developing countries including in Indonesia will also
induce the increasing prevalence of gallstone in our
country. There has been no study yet in the national
scale about the prevalence of gallstone disease in
Indonesia. The risk factor of gallstone formation
including obesity, estrogen, ethnic/race, gender, age,
cholesterol lowering drugs, diabetic drugs, rapid weight
loss, and prolonged fasting.2
Diabetes Mellitus (DM) is a metabolic disease with
high prevalence among the population. The prevalence
of this disease is increasing in accordance to life style
changes in the society. Gallstone is frequently found in
diabetic patients especially in women with type 2
DM.3,4 Nevertheless, studies on the prevalence of
gallstone among diabetic patients population have shown
inconsistent/contradictive result.5 This article will
review the correlation between DM and its effect on
gallstone, particularly in the aspect of pathogenesis and
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the treatment. With better understanding on the risk
factors, especially diabetes, hopefully we will also be
able to prevent and provide better treatment for the
patient.
EPIDEMIOLOGY
Reports of two studies: the autopsy and epidemio-
logic study show conflicting result. Large scale case
control study in Canada did not reveal the correlation
between cholesterol cholelithiasis and DM.5,6 Several
supporting studies include the cohort study conducted
by Pangliarulo et al. The study showed that the
prevalence of gallstone formation is significantly higher
in the DM population compared to general population
(24.8% versus 13.8%).5 The prevalence of gallstone
formation is two to three times higher in diabetic
patients compared to non-diabetic patients.7
Furthermore hyperinsulinemia, insulin resistance,
beta cell dysfunction, are also associated with the risk
factor of gallstone formation in women with type 2
DM.3
Epidemiologic study in Italy showed that there were
multiple risk factors (e.g. hyperinsulinemia, age,
obesity, type 2 DM) associated with the formation of
gallstone.8 Recent study shows that diabetes is
associated with gallstone formation in univariate analysis
but not in multivariate analysis.9 On the other hand,
age and obesity, that are frequently found in type 2
DM patients, are strong risk factors for the
development of gallstone.3,9,10,11 Study conducted by
Alokaba, et al. in Nigeria reported that increased age
is a risk factor for gallstone formation in diabetic
patients. Hyperlipidemia, overweight, female gender,
duration of DM disease were also associated with such
risk factor.12,13
PATHOGENESIS AND THE EFFECT OF DIABETES
MELLITUS ON GALLSTONE
There are two types of gallstone, i.e. cholesterol
stone and pigment stone. Cholesterol stone is usually
in yellow-greenish color and mostly derived from
hardened cholesterol. Eighty percent of gallstone is
Table 1. Differences on pathogenesis and clinical correlation between cholesterol stone and pigment stone14 
Characteristics Cholesterol stone Black pigmented stone Brown pigmented stone 
Anatomic location Gallbladder  Gallbladder   Bile duct and gallbladder  
Geographic and clinical 
association 
Western countries overweight/obesity, 
diabetes, pregnancy, sedentary life 
style 
Western and Asian countries, 
chronic hemolysis, cirrhosis, 
healthy person 
Mostly in Asia, biliary 
infection         
Bile culture Usually sterile Usually sterile Infected (enteric and 
anaerobic organism) 
Major component  Cholesterol, calcium 
bilirubinate/carbonate 
Pigment polymer, calcium 
phosphate/carbonate 
Calcium bilirubinate, 
calcium, fatty acid, 
cholesterol 
Etiology Cholesterol, hypersecretion, 
gallbladder stasis, pro nuclease factors 
in bile 
Increased excretion and 
hydrolysis of conjugated 
bilirubin 
Bacterial hydrolysis, bile 
stasis 
 
cholesterol stone. Some of the gallstone is pigment stone,
dark colored and made from bilirubin.14
Genetic Factors and Environment
In western countries, more than 75% of gallstones
are cholesterol type. There are different prevalences
of gallstone according to ethnic group in a country, this
condition indicates the evidence that genetic factor
affects the incidence of gallstone formation. In America,
the highest prevalence is found in Pima Indian North
America, Chilean, and Caucasians. In Asian
population, the prevalence is low; but there is medium
prevalence in European countries. The role of genetic
factor in gallstone formation has been proven through
animal experimental study.14
The influence of environmental factor is very
supportive in the progressive increase of gallstone
prevalence. Recent studies have demonstrated
significant evidences that lifestyle and behavior factor
including central obesity, low physical activity, diet, and
drugs are predisposing factors for symptomatic/
asymptomatic gallstone. Insulin resistance that is
frequently found in type 2 DM patients is the
 underlying mechanism associating/correlating obesity,
central adiposity, and low physical activity with
gallstone disease.14
Studies conducted by Misciagna et al, Pagliarulo et
al, Chi Ming Liu et al, and Constance et al have
demonstrated evidence that hyperinsulinemia, insulin
resistance, beta cell dysfunction, obesity, family
history of gallstone were associated with risk factors
of gallstone formation in women with type 2 DM.3,7,15,16
Figure 1. Two types of gallstone; white (cholesterol stone), brown/
black (pigment stone).2
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Synthesis and Metabolism of Biliary Fat
Bile is fluid substance containing lipid, protein, and
electrolyte. There are three kinds of major biliary lipid/
fat, i.e: cholesterol, bile acid, and phospholipids (mainly
phosphatidylcholine). In addition, protein derives from
serum, which is synthesized by the liver, bile duct and
gallbladder epithelium. Gallstone formation is determined
by chemical and physical interaction between various
biliary lipid and biliary protein as follows.:14,17
 (1) Cholesterol solubilization: Biliary secretion is
the main pathway of cholesterol elimination.
Cholesterol is not water soluble in nature and it may
easily become water-soluble with the addition of bile.
Within the bile, cholesterol is dissolved with biliary lipid,
bile salt, and phospholipids. Maximal cholesterol solu-
bility to be eliminated from the body is defined by
cholesterol saturation index (CSI). In vitro, CSI can
be calculated by the ratio of the amount of cholesterol
and bile to reach the maximum capacity of cholesterol
transport. Supersaturation is defined if CSI >1;14,17 (2)
Cholesterol supersaturation; Cholesterol secreted by
the liver sometimes exceeds the transport capacity of
biliary lipid that makes the bile becomes supersaturated
and easily get precipitated. The failure in maintaining
the homeostasis of biliary secretion results in biliary
cholesterol hypersecretion or relative hyposecretion of
bile acid. Clinical condition associated with biliary
cholesterol hypersecretion including obesity, rapid
weight loss, increasing age, effect of drug treatment
(e.g. clofibrate, estrogen, and progesterone). Clinical
condition associated with relative hyposecretion of the
bile acid e.g. chronic cholestatic disease; ileal
disease;14,17 (3) Cholesterol crystal nucleation; The early
stage of gallstone formation is the formation of stone
nucleus and precipitation of solid cholesterol crystal in
saturated bile (nucleation). Several studies found that
there are factors that may increase the nucleation
(pronucleation) or inhibit the nucleation (anti-nucleation)
in animal study in vitro. Pro-nucleation factors e.g.
mucin of the gallbladder, alpha-1 glycoproteinic acid,
aminopeptidase N, immunoglobulin M and G,
haptoglobin, fibronectin and alpha-1 antichemotrypsin.
Moreover, anti-nucleation factors include biliary
protein, immunoglobulin A and apolipoprotein AI and
AII. If this early stage (nucleation) continues, it will
increase precipitated and hardened cholesterol crystal
leading to the gallstone formation.14
The Role of Gallbladder
Gallbladder itself has an important role in the
formation of cholesterol stone especially its mucosal
layer and its motility. Gallbladder does not only serve
as a storage organ; moreover, it absorps water,
secretes hydrogen ion, concentrates and acidifies the
bile. Principally, gallbladder modifies the solubility of
cholesterol, calcium, and bilirubin. Thus, gallbladder
concentrates and promotes the nucleation process.
Gallbladder also produces mucin as an important
pronucleus factor.14,17
Altered lipid metabolism in the mucosal layer of the
gallbladder also contributes to gallstone formation. In
physiologic condition, gallbladder absorps phospholipid
and cholesterol from the bile, decreasing the bile
hardening. In contrast, gallbladder in patients with cho-
lesterol stone absorps less phospholipid and
cholesterol.14,17
The gallbladder motility is one of the key factors.
Gallbladder dysmotility and stasis are other risk
factors for the formation of cholesterol stone. In
human, prolonged parenteral nutrition may induce
stasis and dysmotility of the gallbladder that promote
the formation of the bile sludge. Pregnancy, oral
contraceptive, obesity, diabetes mellitus, and ocreotide
treatment are also associated with the weakness of
gallbladder emptying and promote the gallstone
formation. Gallbladder stasis makes the bile more
concentrated and enhances the gallstone formation
(lithogenic), as well as facilitates cholesterol crystal
precipitation. In contrast, adequate gallbladder motility
will remove cholesterol crystal quickly from the
gallbladder and prevent the formation of gallstone.14
Diabetic patients are at increased risk of gallstone
formation for two important physiologic reasons, i.e.:5
(1) Increased total cholesterol synthesis in the body
that promote easier cholesterol stone formation from
the bile (lithogenic); (2) Diabetic patients have larger
gallbladder with probably reduced motility that increase
the formation of cholesterol crystal.5,18,19 However,
recent study suggests that diabetes mellitus alone
without any contribution from other factors is not
significant in increasing the risk for gallstone
formation. 5
Haber and Heaton examined lipid composition of
the bile in diabetic patients and in control group. There
were no significant difference in biliary cholesterol
saturation in type 1 or type 2 DM patients compared to
the control group. Type 1 DM patients have un-
saturated bile to the cholesterol; while type 2 DM pa-
tients with higher body mass index (BMI) have more
saturated bile compared to type 1 DM patients. There-
fore, the risk of lithogenic stone was greater for type 2
DM patients than in type 1 DM patients and it has
more correlation to the obesity than the diabetes.
Similar fact has also been demonstrated by other
studies, i.e. diabetes alone did not predispose
abnormal secretion of the bile. There were no
significant correlation between diabetes and the type
of gallstone e.g. pigment stone or cholesterol stone, if
other variables had been corrected such as the
presence of cirrhosis, pigment, and cholesterol.20
In physiologic condition, the liver secretes
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unsaturated bile. The presence of cholesterol, bile salt,
and lecithin in the bile preserve the cholesterol in stable
solubility.21 Pathologic conditions that cause reduced
bile salt secretion or increased cholesterol secretion
will produce supersaturated bile formation with
cholesterol, which result in more lithogenic bile and may
develop into the formation of cholesterol crystal or even
gallstone. Several risk factors that underlies lithogenic
bile secretion are: the increased age, obesity,
hypertriglyceridemia, and reduced bile salt depo.22
Cholecystographic study showed slower/reduced
gallbladder emptying in diabetic patients.23 Similar
studies using ultrasonography and scintigraphy for
analyzing gallbladder emptying showed contradictive/
inconsistent result. Most of reduced/weak gallbladder
emptying in diabetic patients are associated with the
presence of autonomic neuropathic complication.
However, it was still difficult to determine the
difference of motoric function/dysfunction of the
gallbladder from such studies.5
MANAGEMENT/TREATMENT
Two-third of gallstone patients is asymptomatic and
the annual risk for biliary colic is about 1-4%. Preven-
tive cholecystectomy is not recommended since
asymptomatic patients rarely develop serious
complication.1,2 Patients with symptomatic gallstone will
develop complication for about 1-2% each year and
50% of them will have reccurent episode of biliary colic.
Therefore, definitive therapy (surgery) is recommended
for symptomatic patients.1,2
Cholecystectomy
The role of surgery in diabetic patients with asymp-
tomatic gallstone is still controversial. In the past, it
was believed that DM patients with asymptomatic
cholelithiasis should better have surgery to prevent
further increased mortality and morbidity. This
aggressive therapy was proposed by Rabinowitch in
1932. He stated that DM patients with cholecystitis
will have worse complication than non-diabetic
patients.5 In 1961, Turrill et al, reported that the
mortality rate after gallstone surgery was increased to
five-fold in diabetic patients.5
Other authors also stated similar facts; i.e. there is
increased mortality and morbidity in patients who have
undergone emergency cholecystectomy. Limited
analysis in diabetic patients in the 5th-6th decades of
age that have undergone cholecystectomy showed
20-fold increased mortality compared to non-diabetic
patients. Another author suggested elective surgery for
diabetic patients. The rate of mortality and morbidity
in diabetic patients underwent elective surgery was
similar to non-diabetic patients. Both Turril et al and
Mundth recommend all diabetic patients to undergo
screening and oral cholecystography and when there
is gallstone, elective surgery will be conducted.5 Ileus
gallstone is one of the rare complication of post-
cholecystectomy cholelithiasis that may lead to
serious and fatal condition. It is reported to increase
the mortality rates by 7.5-15%, which is usually
associated with elderly women, diabetes mellitus, and
cardiorespiratory impairment.24,25
In the later study, diabetic patients showed lower
morbidity and mortality than the previous reports. These
are first due to advanced development of medical
treatment and surgery, particularly in the era of
antibiotic nowadays. Second, previous studies did not
report the influence of comorbidity in diabetic patients
(e.g. atherosclerosis) that probably may contribute to
the increased post-operative mortality. Finally,
previous studies did not use either appropriate control
group or similar period of observation, which none of
final data suggests elective cholecystectomy for
asymptomatic gallstone patients. However, since
emergency cholecystectomy in patients with acute
cholecystitis is associated with the increased
morbidity and mortality, we should consider elective
cholecystectomy in diabetic patients with biliary
symptoms especially when there are no serious
comorbidity existed. Laparoscopic cholecystectomy is
recommended and is probably safer than abdominal
cholecystectomy.5
Non-surgical Treatment (Medical Dissolution)
This method is suitable for patient who is unable to
undergo definitive treatment by laparoscopic or open
cholecystectomy. Two bile acid, i.e. cenodioxycholic
acid (3 alpha, 7 alpha-Dihydroxycholanoic acid
(CDCA) and 7 beta epimer (3 alpha, 7 beta
dihydroxycholanoic acid, ursodioxycholic acid) had been
widely used for gallstone dissolution. These two bile
acids induce the secretion of less/un-saturated hepatic
bile, and do not increase the absolute amount of bile
acid secretion. Biological effect of CDCA and UDCA
treatment include suppression of hepatic cholesterol
synthesis by inhibiting hydroxymethyl glutaryl Co-A
reductase, increasing the activity of 7 alpha hydroxy-
lase, and reducing cholesterol absorption in the
intestine.
The recommended dosage is 8–12 mg/kg body
weight/day. Preparation of patient selection is the most
important factor for success of such treatment. It is
indicated for cholesterol stone (radiolucent stone), small
stone (diameter < 5 mm), and well-functioned cystic
duct.15
CONCLUSION
Diabetes mellitus is a risk factor that should be
concerned in gallstone formation. Insulin resistance,
hyperinsulinemia, increased cholesterol synthesis,
impairments of gallbladder motility or gallbladders
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emptying due to autonomic neuropathy are factors
associated with increased incidence of gallstone
formation in diabetic patients. However, diabetes
mellitus do not contribute significantly to the gallstone
formation without the presence of the other risk
factors. Elective surgery with laparoscopic cholecys-
tectomy is the treatment of choice and it is only
indicated for symptomatic patients.
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